The Latest Cannabis Articles from Streetwise Reports

Flora Shares Sprout Higher on H1 Financial Results and Positive FY Sales Outlook

Shares of natural cannabis firm Flora Growth Corp. rose 43% after the company reported H1/21 financial results and indicated it expects H2/21 revenues will be in the range of US$9-11 million. read more >
News Update

Cannabis Products Retailer Achieves Record Sales in Q3 FY21

News Update
Gross sales of Stem Holdings dba Driven by Stem during the quarter were 104% higher than they were a year ago. read more >

U.S. Cannabis Sector to Show 'Secular Growth With Margin Improvements,' Analyst Says

Research Report
Behind that forecast, in part, are positive cannabis legislative developments and increasing consumer cannabis use, which are covered in a ROTH Capital Partners report. read more >

Tilray Shares Fly High on Strong Q4 and FY Revenue Growth

Shares of Tilray Inc. traded 25% higher after the company reported FY/21 financial results that included a 27% YoY increase in net revenues to $513.1 million driven by a 55% growth in cannabis revenue following its Aphria acquisition. read more >

Cannabis Market Delivering for Consumers and Investors

As legalization takes hold across the U.S., opportunities for the next generation of cannabis companies expand. Adrian Morante of K2 & Associates finds “trustworthy, capable and reputable” companies with value. read more >

US Cannabis Sales Hold Strong as Industry Lays Out New Lobbying Efforts to Expedite Federal Reform

Contributed Research
McAlinden Research Partners expects activity and revenues in the cannabis space to continue ramping up as the US crosses the point at which legalization is not a question of "if" but "when." read more >

Tilray Shares Climb Higher on Roll Out of New Medical Cannabis Brand Symbios

Tilray Inc. shares traded 11% higher after the company reported the launch of a new medical cannabis brand, Symbios, designed to provide medicinal users with a broader spectrum of formats and cannabinoid potencies at improved price points. read more >
Showing Results: 1 to 7 of 7

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts